Cell And Gene Therapy Supply Chain/Logistics Global Market Report 2024

Request Free Sample Buy Report

Global Cell And Gene Therapy Supply Chain or Logistics Market Report 2024

Cell And Gene Therapy Supply Chain/Logistics Global Market Report 2024 – By Type Of Software Solution (Cell Orchestration Platform, Enterprise Manufacturing System, Inventory Management System, Laboratory Information Management System, Logistics Management System, Patient Management System, Quality Management System, Tracking And Tracing System), By Mode Of Deployment (Cloud-Based Solution, On-Premises Solution), By Component (Cryogenic Shippers, Cryogenic Storage Freezers, Ultra-Low Freezers, Cold Chain Management Systems, Shipment, Storage Medium, Cryogenic Packout Kits, Other Components), By Application Area (Donor Eligibility Assessment, Sample Collection, Manufacturing, Logistics, Patient Verification, Treatment Follow-Up), By End User (Biobank, Cell Therapy Lab, Hospital, Research Institute, Commercial Organization) – Market Size, Trends, And Global Forecast 2024-2033

Starting Price : $5000.00 | Pages : | Published : January 2024 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options

Request Sample

Request For Discount

FAQs

Need assistance or more information before the purchase?

Enquire Before Buying

Cell And Gene Therapy Supply Chain/Logistics Global Market Report 2024

Proud Members Of

Cell And Gene Therapy Supply Chain/Logistics Market Definition And Segments

Cell and gene therapy supply chains and logistics refer to the processes and activities involved in efficiently and effectively managing the flow of materials, information, and resources needed to develop, manufacture, and distribute cell and gene therapies from their initial production to their final administration to patients. These services provide cutting-edge treatments to patients while maintaining the highest safety and efficacy standards throughout the supply chain.

The main types of software solutions are cell orchestration platforms, enterprise manufacturing systems, inventory management systems, laboratory information management systems, logistics management systems, patient management systems, quality management systems, and tracking and tracing systems. A cell orchestration platform refers to a software or technological platform that facilitates the coordination, management, and integration of various processes and activities involved in cell therapy development, manufacturing, and delivery and is used to help streamline and automate tasks related to cell sourcing, manufacturing, quality control, logistics, patient tracking, and data management. They are deployed as a cloud-based solution; an on-premises solution in cryogenic shippers; cryogenic storage freezers; ultra-low freezers; cold chain management systems; shipment; storage medium; cryogenic packout kits; and other components. These solutions are used in applications such as donor eligibility assessment, sample collection, manufacturing, logistics, patient verification, and treatment follow-up by end users including biobanks, cell therapy labs, hospitals, research institutes, and commercial organizations.

The cell and gene therapy supply chain/logistics market covered in this report is segmented –

1) By Type Of Software Solution: Cell Orchestration Platform, Enterprise Manufacturing System, Inventory Management System, Laboratory Information Management System, Logistics Management System, Patient Management System, Quality Management System, Tracking And Tracing System

2) By Mode Of Deployment: Cloud-Based Solution, On-Premises Solution

3) By Component: Cryogenic Shippers, Cryogenic Storage Freezers, Ultra-Low Freezers, Cold Chain Management Systems, Shipment, Storage Medium, Cryogenic Packout Kits, Other Components

4) By Application Area: Donor Eligibility Assessment, Sample Collection, Manufacturing, Logistics, Patient Verification, Treatment Follow-Up

5) By End User: Biobank, Cell Therapy Lab, Hospital, Research Institute, Commercial Organization

The cell and gene therapy supply chain/logistics market size has grown rapidly in recent years. It will grow from $1.25 billion in 2023 to $1.4 billion in 2024 at a compound annual growth rate (CAGR) of 12.6%. The growth in the historic period can be attributed to growth in prevalence of chronic diseases, efficient use of supply chain requirements, rise in maintenance the drug integrity, evolved regulatory frameworks, increased emphasis on risk mitigation and compliance.

The cell and gene therapy supply chain/logistics market size is expected to see rapid growth in the next few years. It will grow to $2.15 billion in 2028 at a compound annual growth rate (CAGR) of 11.2%. The growth in the forecast period can be attributed to expansion of personalized medicine, development of cell-free therapies, growing prevalence of chronic diseases, growing global cell therapy manufacturing market, efficient use of supply chain requirements. Major trends in the forecast period include increased research and development expenditure, adoption of advanced technologies, favorable initiatives and programs for easier access, partnerships and collaborations between cell and gene therapy companies, supply chain providers, and logistics companies, providing of customizable services to support any point of patient identification.

The Surging Demand For Cell And Gene Therapies Reshapes Supply Chain And Logistics

The increasing need for cell and gene therapies is driving the cell and gene therapy supply chain/logistics market. Cell and gene therapies are advanced medical treatments that modify cells or genes to treat diseases, offering potential breakthroughs for untreatable conditions. These cell and gene therapies need to be stored at the proper temperature and storage conditions, which can be achieved using supply chain and logistics services, which help from sourcing to distributing and storing these cell and gene therapies. For instance, in February 2022, according to Cell & Gene, a US-based online resource for research scholars, the private investment in cell and gene therapy in 2021 was $68 billion. Moreover, the number of approved cell and gene therapies experienced a 10% growth in 2021. Therefore, the increasing need for cell and gene therapies drives the cell and gene therapy supply chain/logistics market forward.

Personalized Medicine Boom Drives Cell And Gene Therapy Supply Chain And Logistics Market

The increasing demand for personalized medicine is expected to propel the growth of the cell and gene therapy supply chain/logistics market going forward. Personalized medicine refers to an innovative approach to medical treatment and healthcare that tailors medical decisions, practices, interventions, and drug therapies to the individual patient. Cell and gene therapy supply chain/logistics are used to deliver safely and effectively precision medicines to meet the unique needs of individual patients with incorporate temperature monitoring to maintain the integrity throughout the supply chain. For instance, in October 2022, according to reports published by STAT, a US-based health-oriented news company, there were more than 75,000 genetic testing products and 300 personalized medicines. Therefore, the increasing demand for personalized medicine is driving the growth of the cell and gene therapy supply chain/logistics market.

Major companies operating in the cell and gene therapy supply chain/logistics market report are AmerisourceBergen Corporation, United Parcel Service, Thermo Fisher Scientific Inc., Avantor Sciences, Lonza Group AG, Arvato Group, Catalent Inc., Charles River Laboratories International, Parexel International Corporation, Cytiva, Almac Group, World Courier, Sharp Packaging Services, PCI Pharma Services, Cryoport Inc., Brooks Life Sciences, BioLife Solutions Inc., Biocair Inc., QuickSTAT, Clarkston Consulting Inc., Central Pharma, TrakCel limited, MAK-SYSTEM International Group, Hypertrust Patient Data Care GmbH, Atelerix Ltd., Polar Express Transportation, Be The Match BioTherapies Inc., Yourway Biopharma Services Company, Azenta Life Sciences Inc., Biostor Ltd.

Advancements In Technology Propel Cell And Gene Therapy Logistics

Modern technology platforms are a key trend gaining popularity in the cell and gene therapy supply chain/logistics markets. Major companies operating in the market are developing modern technology platforms for cell and gene therapies to sustain their position in the market. For instance, in April 2023, AmerisourceBergen Corporation., a US-based healthcare company specializing in cell and gene therapy supply chain logistics, launched the Cell and Gene Therapy (CGT) Integration Hub. The Cell and Gene Therapy (CGT) Integration Hub is powered by AmerisourceBergen’s innovative customer relationship management (CRM) system. It can be integrated into the biopharma platform to facilitate better monitoring of the development and delivery of cell and gene therapies.

Next Generation Platforms Reshaping Cell And Gene Therapy Supply Chains

Major companies operating in the cell and gene therapy supply chain and logistics are focused on introducing next-generation solutions, such as the off-the-shelf cell orchestration platform. Off-the-shelf cell orchestration platforms are platforms that provide streamlined supply chain management, pre-designed modules, industry-proven processes, quick deployment, and integration. For instance, in January 2022, TrakCel Limited, a UK-based software company, launched OCELLOS Lite. OCELLOS Lite is a pre-designed, modular, and validated solution for managing the supply chain and logistics of cell and gene therapies. It allows companies to manage supply chain processes through the clinical phases of development into commercialization and can be deployed in weeks, which makes it one of the simplest and quickest solutions.

Cryoport Strengthens Global Supply Chain For Regenerative Medicine Through Acquisition Of Cell And Co Bioservices

In April 2022, Cryoport Systems LLC, a US-based temperature-controlled logistics services provider, acquired Cell&Co BioServices for $6.2 million. The acquisition helped Cryoport expand its global supply chain network and meet the needs of the regenerative medicine industry. Cell&Co BioServices is a France-based supply chain management services provider for biological, pharmaceutical, and clinical samples throughout their life cycle.

North America was the largest region in the cell and gene therapy supply chain/logistics market in 2023. The regions covered in the cell and gene therapy supply chain/logistics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the cell and gene therapy supply chain/logistics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The cell and gene therapy supply chain and logistics market includes revenues earned by entities by providing sourcing and collection, quality testing, distribution, and transportation services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The cell and gene therapy supply chain/logistics research report is one of a series of new reports from The Business Research Company that provides cell and gene therapy supply chain/logistics market statistics, including the cell and gene therapy supply chain/logistics industry's global market size, regional shares, competitors with a cell and gene therapy supply chain/logistics market share, detailed cell and gene therapy supply chain/logistics market segments, market trends and opportunities, and any further data you may need to thrive in the cell and gene therapy supply chain/logistics industry. This cell and gene therapy supply chain/logistics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Cell And Gene Therapy Supply Chain/Logistics Market Report Scope

Report Attribute	Details
Market Size Value In 2024	$1.4 billion
Revenue Forecast In 2033	$2.15 billion
Growth Rate	CAGR of 11.2% from 2024 to 2033
Base Year For Estimation	2023
Actual Estimates/Historical Data	2018-2023
Forecast Period	2024 - 2028 - 2033
Market Representation	Revenue in USD Billion and CAGR from 2024 to 2033
Segments Covered	1) By Type Of Software Solution: Cell Orchestration Platform, Enterprise Manufacturing System, Inventory Management System, Laboratory Information Management System, Logistics Management System, Patient Management System, Quality Management System, Tracking And Tracing System 2) By Mode Of Deployment: Cloud-Based Solution, On-Premises Solution 3) By Component: Cryogenic Shippers, Cryogenic Storage Freezers, Ultra-Low Freezers, Cold Chain Management Systems, Shipment, Storage Medium, Cryogenic Packout Kits, Other Components 4) By Application Area: Donor Eligibility Assessment, Sample Collection, Manufacturing, Logistics, Patient Verification, Treatment Follow-Up 5) By End User: Biobank, Cell Therapy Lab, Hospital, Research Institute, Commercial Organization
Regional Scope	Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Country Scope	Australia; China; India; Indonesia; Japan; South Korea; Bangladesh; Thailand; Vietnam; Malaysia; Singapore; Philippines; Hong Kong; New Zealand; USA; Canada; Mexico; Brazil; Chile; Argentina; Colombia; Peru; France; Germany; UK; Austria; Belgium; Denmark; Finland; Ireland; Italy; Netherlands; Norway; Portugal; Spain; Sweden; Switzerland; Russia; Czech Republic; Poland; Romania; Ukraine; Saudi Arabia; Israel; Iran; Turkey; UAE; Egypt; Nigeria; South Africa
Key Companies Profiled	AmerisourceBergen Corporation; United Parcel Service; Thermo Fisher Scientific Inc.; Avantor Sciences; Lonza Group AG; Arvato Group; Catalent Inc.; Charles River Laboratories International; Parexel International Corporation; Cytiva; Almac Group; World Courier; Sharp Packaging Services; PCI Pharma Services; Cryoport Inc.; Brooks Life Sciences; BioLife Solutions Inc.; Biocair Inc.; QuickSTAT; Clarkston Consulting Inc.; Central Pharma; TrakCel limited; MAK-SYSTEM International Group; Hypertrust Patient Data Care GmbH; Atelerix Ltd.; Polar Express Transportation; Be The Match BioTherapies Inc.; Yourway Biopharma Services Company; Azenta Life Sciences Inc.; Biostor Ltd.
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

Table Of Contents

1. Executive Summary

2. Cell And Gene Therapy Supply Chain/Logistics Market Characteristics

3. Cell And Gene Therapy Supply Chain/Logistics Market Trends And Strategies

4. Cell And Gene Therapy Supply Chain/Logistics Market - Macro Economic Scenario

4.1. Impact Of High Inflation On The Market

4.2. Ukraine-Russia War Impact On The Market

4.3. COVID-19 Impact On The Market

5. Global Cell And Gene Therapy Supply Chain/Logistics Market Size and Growth

5.1. Global Cell And Gene Therapy Supply Chain/Logistics Market Drivers and Restraints

5.1.1. Drivers Of The Market

5.1.2. Restraints Of The Market

5.2. Global Cell And Gene Therapy Supply Chain/Logistics Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)

5.3. Global Cell And Gene Therapy Supply Chain/Logistics Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Cell And Gene Therapy Supply Chain/Logistics Market Segmentation

6.1. Global Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Cell Orchestration Platform

Enterprise Manufacturing System

Inventory Management System

Laboratory Information Management System

Logistics Management System

Patient Management System

Quality Management System

Tracking And Tracing System

6.2. Global Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Cloud-Based Solution

On-Premises Solution

6.3. Global Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Cryogenic Shippers

Cryogenic Storage Freezers

Ultra-Low Freezers

Cold Chain Management Systems

Shipment

Storage Medium

Cryogenic Packout Kits

Other Components

6.4. Global Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Donor Eligibility Assessment

Sample Collection

Manufacturing

Logistics

Patient Verification

Treatment Follow-Up

6.5. Global Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Biobank

Cell Therapy Lab

Hospital

Research Institute

Commercial Organization

7. Cell And Gene Therapy Supply Chain/Logistics Market Regional And Country Analysis

7.1. Global Cell And Gene Therapy Supply Chain/Logistics Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

7.2. Global Cell And Gene Therapy Supply Chain/Logistics Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Cell And Gene Therapy Supply Chain/Logistics Market

8.1. Asia-Pacific Cell And Gene Therapy Supply Chain/Logistics Market Overview

Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8.3. Asia-Pacific Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8.4. Asia-Pacific Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Cell And Gene Therapy Supply Chain/Logistics Market

9.1. China Cell And Gene Therapy Supply Chain/Logistics Market Overview

9.2. China Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

9.3. China Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

9.4. China Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Cell And Gene Therapy Supply Chain/Logistics Market

10.1. India Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

10.2. India Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

10.3. India Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Cell And Gene Therapy Supply Chain/Logistics Market

11.1. Japan Cell And Gene Therapy Supply Chain/Logistics Market Overview

11.2. Japan Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11.3. Japan Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11.4. Japan Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Cell And Gene Therapy Supply Chain/Logistics Market

12.1. Australia Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12.2. Australia Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12.3. Australia Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Cell And Gene Therapy Supply Chain/Logistics Market

13.1. Indonesia Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13.2. Indonesia Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13.3. Indonesia Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Cell And Gene Therapy Supply Chain/Logistics Market

14.1. South Korea Cell And Gene Therapy Supply Chain/Logistics Market Overview

14.2. South Korea Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14.3. South Korea Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14.4. South Korea Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Cell And Gene Therapy Supply Chain/Logistics Market

15.1. Western Europe Cell And Gene Therapy Supply Chain/Logistics Market Overview

15.2. Western Europe Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15.3. Western Europe Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15.4. Western Europe Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Cell And Gene Therapy Supply Chain/Logistics Market

16.1. UK Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16.2. UK Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16.3. UK Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Cell And Gene Therapy Supply Chain/Logistics Market

17.1. Germany Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17.2. Germany Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17.3. Germany Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Cell And Gene Therapy Supply Chain/Logistics Market

18.5. France Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18.6. France Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18.7. France Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Cell And Gene Therapy Supply Chain/Logistics Market

19.9. Italy Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19.10. Italy Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19.11. Italy Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Cell And Gene Therapy Supply Chain/Logistics Market

20.13. Spain Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20.14. Spain Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20.15. Spain Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Cell And Gene Therapy Supply Chain/Logistics Market

21.1. Eastern Europe Cell And Gene Therapy Supply Chain/Logistics Market Overview

21.2. Eastern Europe Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21.3. Eastern Europe Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21.4. Eastern Europe Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Cell And Gene Therapy Supply Chain/Logistics Market

22.1. Russia Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22.2. Russia Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22.3. Russia Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Cell And Gene Therapy Supply Chain/Logistics Market

23.1. North America Cell And Gene Therapy Supply Chain/Logistics Market Overview

23.2. North America Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23.3. North America Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23.4. North America Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Cell And Gene Therapy Supply Chain/Logistics Market

24.1. USA Cell And Gene Therapy Supply Chain/Logistics Market Overview

24.2. USA Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24.3. USA Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24.4. USA Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Cell And Gene Therapy Supply Chain/Logistics Market

25.1. Canada Cell And Gene Therapy Supply Chain/Logistics Market Overview

25.2. Canada Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25.3. Canada Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25.4. Canada Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Cell And Gene Therapy Supply Chain/Logistics Market

26.1. South America Cell And Gene Therapy Supply Chain/Logistics Market Overview

26.2. South America Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26.3. South America Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26.4. South America Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Cell And Gene Therapy Supply Chain/Logistics Market

27.1. Brazil Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27.2. Brazil Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27.3. Brazil Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Cell And Gene Therapy Supply Chain/Logistics Market

28.1. Middle East Cell And Gene Therapy Supply Chain/Logistics Market Overview

28.2. Middle East Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28.3. Middle East Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28.4. Middle East Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Cell And Gene Therapy Supply Chain/Logistics Market

29.1. Africa Cell And Gene Therapy Supply Chain/Logistics Market Overview

29.2. Africa Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29.3. Africa Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29.4. Africa Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Cell And Gene Therapy Supply Chain/Logistics Market Competitive Landscape And Company Profiles

30.1. Cell And Gene Therapy Supply Chain/Logistics Market Competitive Landscape

30.2. Cell And Gene Therapy Supply Chain/Logistics Market Company Profiles

30.2.1. AmerisourceBergen Corporation

30.2.1.1. Overview

30.2.1.2. Products and Services

30.2.1.3. Strategy

30.2.1.4. Financial Performance

30.2.2. United Parcel Service

30.2.2.1. Overview

30.2.2.2. Products and Services

30.2.2.3. Strategy

30.2.2.4. Financial Performance

30.2.3. Thermo Fisher Scientific Inc.

30.2.3.1. Overview

30.2.3.2. Products and Services

30.2.3.3. Strategy

30.2.3.4. Financial Performance

30.2.4. Avantor Sciences

30.2.4.1. Overview

30.2.4.2. Products and Services

30.2.4.3. Strategy

30.2.4.4. Financial Performance

30.2.5. Lonza Group AG

30.2.5.1. Overview

30.2.5.2. Products and Services

30.2.5.3. Strategy

30.2.5.4. Financial Performance

31. Cell And Gene Therapy Supply Chain/Logistics Market Other Major And Innovative Companies

31.1. Arvato Group

31.2. Catalent Inc.

31.3. Charles River Laboratories International

31.4. Parexel International Corporation

31.5. Cytiva

31.6. Almac Group

31.7. World Courier

31.8. Sharp Packaging Services

31.9. PCI Pharma Services

31.10. Cryoport Inc.

31.11. Brooks Life Sciences

31.12. BioLife Solutions Inc.

31.13. Biocair Inc.

31.14. QuickSTAT

31.15. Clarkston Consulting Inc.

32. Global Cell And Gene Therapy Supply Chain/Logistics Market Competitive Benchmarking

33. Global Cell And Gene Therapy Supply Chain/Logistics Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Cell And Gene Therapy Supply Chain/Logistics Market

35. Cell And Gene Therapy Supply Chain/Logistics Market Future Outlook and Potential Analysis

35.1 Cell And Gene Therapy Supply Chain/Logistics Market In 2028 - Countries Offering Most New Opportunities

35.2 Cell And Gene Therapy Supply Chain/Logistics Market In 2028 - Segments Offering Most New Opportunities

35.3 Cell And Gene Therapy Supply Chain/Logistics Market In 2028 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2018-2023, $ Billion

Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion

Table 3: Global Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 4: Global Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 5: Global Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 6: Global Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 7: Global Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 8: Global Cell And Gene Therapy Supply Chain/Logistics Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 9: Global Cell And Gene Therapy Supply Chain/Logistics Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 10: Asia-Pacific, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 11: Asia-Pacific, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 12: Asia-Pacific, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 13: China, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 14: China, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 15: China, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 16: India, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 17: India, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 18: India, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 19: Japan, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 20: Japan, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 21: Japan, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 22: Australia, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 23: Australia, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 24: Australia, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 25: Indonesia, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 26: Indonesia, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 27: Indonesia, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 28: South Korea, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 29: South Korea, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 30: South Korea, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 31: Western Europe, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 32: Western Europe, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 33: Western Europe, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 34: UK, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 35: UK, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 36: UK, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 37: Germany, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 38: Germany, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 39: Germany, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 40: France, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 41: France, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 42: France, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 43: Italy, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 44: Italy, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 45: Italy, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 46: Spain, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 47: Spain, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 48: Spain, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 49: Eastern Europe, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 50: Eastern Europe, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 51: Eastern Europe, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 52: Russia, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 53: Russia, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 54: Russia, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 55: North America, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 56: North America, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 57: North America, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 58: USA, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 59: USA, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 60: USA, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 61: Canada, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 62: Canada, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 63: Canada, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 64: South America, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 65: South America, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 66: South America, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 67: Brazil, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 68: Brazil, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 69: Brazil, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 70: Middle East, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 71: Middle East, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 72: Middle East, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 73: Africa, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 74: Africa, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 75: Africa, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 76: AmerisourceBergen Corporation Financial Performance

Table 77: United Parcel Service Financial Performance

Table 78: Thermo Fisher Scientific Inc. Financial Performance

Table 79: Avantor Sciences Financial Performance

Table 80: Lonza Group AG Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2018-2023, $ Billion

Figure 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion

Figure 3: Global Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 4: Global Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 5: Global Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 6: Global Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 7: Global Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 8: Global Cell And Gene Therapy Supply Chain/Logistics Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 9: Global Cell And Gene Therapy Supply Chain/Logistics Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 10: Asia-Pacific, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 11: Asia-Pacific, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 12: Asia-Pacific, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 13: China, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 14: China, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 15: China, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 16: India, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 17: India, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 18: India, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 19: Japan, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 20: Japan, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 21: Japan, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 22: Australia, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 23: Australia, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 24: Australia, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 25: Indonesia, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 26: Indonesia, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 27: Indonesia, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 28: South Korea, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 29: South Korea, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 30: South Korea, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 31: Western Europe, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 32: Western Europe, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 33: Western Europe, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 34: UK, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 35: UK, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 36: UK, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 37: Germany, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 38: Germany, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 39: Germany, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 40: France, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 41: France, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 42: France, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 43: Italy, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 44: Italy, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 45: Italy, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 46: Spain, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 47: Spain, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 48: Spain, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 49: Eastern Europe, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 50: Eastern Europe, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 51: Eastern Europe, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 52: Russia, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 53: Russia, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 54: Russia, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 55: North America, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 56: North America, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 57: North America, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 58: USA, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 59: USA, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 60: USA, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 61: Canada, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 62: Canada, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 63: Canada, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 64: South America, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 65: South America, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 66: South America, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 67: Brazil, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 68: Brazil, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 69: Brazil, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 70: Middle East, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 71: Middle East, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 72: Middle East, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 73: Africa, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 74: Africa, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 75: Africa, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 76: AmerisourceBergen Corporation Financial Performance

Figure 77: United Parcel Service Financial Performance

Figure 78: Thermo Fisher Scientific Inc. Financial Performance

Figure 79: Avantor Sciences Financial Performance

Figure 80: Lonza Group AG Financial Performance

Forecasting Till 2030: Opportunities And Strategies In The Global Value Based Care Payment Market – Includes Value Based Care Payment Market Analysis

How Will The Nuclear Medicine Market Grow In 2022?

What Is The Pediatric Imaging Market Overview In 2022?

Latest Healthcare Technology Management Market Growth Study 2022-2026 By The Business Research Company

The Business Research Company offers the hospital acquired infection control market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the multiplex assays market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the healthcare it consulting market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the renal biomarkers market research report 2022 with industry size, share, segments and market growth

Cell & Gene Therapy Manufacturing Services Global Market Report 2024 – By Type (Gene Therapy, Cell Therapy), By Indication (Central Nervous System Disorders, Ophthalmology Diseases, Cardiovascular Diseases, Infectious Diseases, Orthopedic Diseases, Oncology Diseases), By Application (Commercial Manufacturing, Clinical Manufacturing), By End-user (Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Other End-Users) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Gene Therapy Global Market Report 2024 – By Gene Therapy Type (Germline Therapy, Somatic Cell Therapy), By Vector (Viral Vector, Non-Viral Vector), By Application (Oncology, Orphan Disease, Knee Osteoarthritis, Neurological Disorders), By End Users (Biopharmaceutical Companies, Research Institutes, Other End Users) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Gene Editing Global Market Report 2024 – By Technology (CRISPR, TALEN, ZFN), By Application (Animal Genetic Engineering, Plant Genetic Engineering, Cell Line Engineering), By End Users (Biotechnology, Pharmaceutical, Contract Research Organization) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Nucleic Acid Based Gene Therapy Global Market Report 2024 – By Technology (Anti-Sence and Anti-Gene, Short Inhibitory Sequences, Gene Transfer Therapy, Nucleoside Analogs, Ribozymes, Aptamers, Other Technologies), By Application (Oncology, Muscular Dystrophy/ Muscular Disorders, Rare Diseases), By End User (Hospitals And Clinics, Academic And Research Institutes) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Cell Culture Consumables And Equipment Global Market Report 2024 – By Product (Consumables, Instruments), By Application (Vaccination, Toxicity testing, Cancer Research, Drug Screening and Development, Recombinant Products, Stem cell technology, Regenerative Medicine, Other End Users), By End User (Industrial, Biotechnology, Agriculture, Other End Users) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Cell Based Assays Global Market Report 2024 – By Product & Service (Consumables, Instruments, Services, Software), By Technology (Automated Handling, Flow Cytometry, Label-Free Detection, High-Throughput Screening, Other Technologies), By Application (Drug Discovery, Basic Research, Adme Studies, Predictive Toxicology, Other Applications), By End User (Pharmaceutical And Biotechnology Companies, Academic And Government Research Institutes, Contract Research Organizations (CRO), Other End Users) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Cell Expansion Global Market Report 2024 – By Cell Type (Mammalian, Microbial, Other Cell Types), By Product (Consumables, Reagents, Media, Serum, Disposables, Instruments ), By Application (Biopharmaceuticals, Tissue Culture & Engineering, Vaccine Production, Drug Development, Gene Therapy, Cancer Research, Stem Cell Research, Other Applications), By End-user (Biopharmaceutical & Biotechnology Companies, Research Institutes, Cell Banks, Other End-Users) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Healthcare Supply Chain Management Global Market Report 2024 – By Component (Software Application, Hardware Type), By Delivery Mode (On-Premise, Cloud Based), By End-User (Healthcare Providers, Healthcare Manufacturers, Other End-Users) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Frequently Asked Questions

What is the definition of the cell and gene therapy supply chain/logistics market?

How will the cell and gene therapy supply chain/logistics market drivers and restraints affect the cell and gene therapy supply chain/logistics market dynamics? What forces will shape the cell and gene therapy supply chain/logistics industry going forward

The cell and gene therapy supply chain/logistics market major growth driver - The Surging Demand For Cell And Gene Therapies Reshapes Supply Chain And Logistics. For further insights on the cell and gene therapy supply chain/logistics market, request a sample here

What is the forecast market size or the forecast market value of the cell and gene therapy supply chain/logistics market?

The cell and gene therapy supply chain/logistics market size has grown rapidly in recent years. It will grow from $1.25 billion in 2023 to $1.4 billion in 2024 at a compound annual growth rate (CAGR) of 12.6%. The growth in the historic period can be attributed to growth in prevalence of chronic diseases, efficient use of supply chain requirements, rise in maintainence the drug integrity, evolved regulatory frameworks, increased emphasis on risk mitigation and compliance. The cell and gene therapy supply chain/logistics market size is expected to see rapid growth in the next few years. It will grow to $2.15 billion in 2028 at a compound annual growth rate (CAGR) of 11.2%. The growth in the forecast period can be attributed to expansion of personalized medicine, development of cell-free therapies, growing prevalence of chronic diseases, growing global cell therapy manufacturing market, efficient use of supply chain requirements. Major trends in the forecast period include increased research and development expenditure, adoption of advanced technologies, favorable initiatives and programs for easier access, partnerships and collaborations between cell and gene therapy companies, supply chain providers, and logistics companies, providing of customizable services to support any point of patient identification. For further insights on the cell and gene therapy supply chain/logistics market, request a sample here

How is the cell and gene therapy supply chain/logistics market segmented?

The cell and gene therapy supply chain/logistics market is segmented
1) By Type Of Software Solution: Cell Orchestration Platform, Enterprise Manufacturing System, Inventory Management System, Laboratory Information Management System, Logistics Management System, Patient Management System, Quality Management System, Tracking And Tracing System
2) By Mode Of Deployment: Cloud-Based Solution, On-Premises Solution
3) By Component: Cryogenic Shippers, Cryogenic Storage Freezers, Ultra-Low Freezers, Cold Chain Management Systems, Shipment, Storage Medium, Cryogenic Packout Kits, Other Components
4) By Application Area: Donor Eligibility Assessment, Sample Collection, Manufacturing, Logistics, Patient Verification, Treatment Follow-Up
5) By End User: Biobank, Cell Therapy Lab, Hospital, Research Institute, Commercial OrganizationFor further insights on the cell and gene therapy supply chain/logistics market, request a sample here

Which region has the largest share of the cell and gene therapy supply chain/logistics market? What are the other regions covered in the report?

North America was the largest region in the cell and gene therapy supply chain/logistics market in 2023. The regions covered in the cell and gene therapy supply chain/logistics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa For further insights on the cell and gene therapy supply chain/logistics market, request a sample here.

Who are the major players in the cell and gene therapy supply chain/logistics market?

What are the key trends in the cell and gene therapy supply chain/logistics market?

Major trend in the cell and gene therapy supply chain/logistics market - Advancements In Technology Propel Cell And Gene Therapy Logistics. For further insights on the cell and gene therapy supply chain/logistics market, request a sample here.

What are the major opportunities in the cell and gene therapy supply chain/logistics market? What are the strategies for the cell and gene therapy supply chain/logistics market?

For detailed insights on the major opportunities and strategies in the cell and gene therapy supply chain/logistics market, request a sample here.

How does the cell and gene therapy supply chain/logistics market relate to the overall economy and other similar markets?

For detailed insights on cell and gene therapy supply chain/logistics market's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the cell and gene therapy supply chain/logistics industry?

For detailed insights on the mergers and acquisitions in the cell and gene therapy supply chain/logistics industry, request a sample here.

What are the key dynamics influencing the cell and gene therapy supply chain/logistics market growth? SWOT analysis of the cell and gene therapy supply chain/logistics market.

For detailed insights on the key dynamics influencing the cell and gene therapy supply chain/logistics market growth and SWOT analysis of the cell and gene therapy supply chain/logistics industry, request a sample here.